Logo image of VRSN

VERISIGN INC (VRSN) Stock Fundamental Analysis

NASDAQ:VRSN - Nasdaq - US92343E1029 - Common Stock - Currency: USD

246.67  +0.74 (+0.3%)

After market: 246.67 0 (0%)

Fundamental Rating

4

Taking everything into account, VRSN scores 4 out of 10 in our fundamental rating. VRSN was compared to 81 industry peers in the IT Services industry. There are concerns on the financial health of VRSN while its profitability can be described as average. While showing a medium growth rate, VRSN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

VRSN had positive earnings in the past year.
In the past year VRSN had a positive cash flow from operations.
Each year in the past 5 years VRSN has been profitable.
Each year in the past 5 years VRSN had a positive operating cash flow.
VRSN Yearly Net Income VS EBIT VS OCF VS FCFVRSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

VRSN has a better Return On Assets (55.86%) than 100.00% of its industry peers.
Industry RankSector Rank
ROA 55.86%
ROE N/A
ROIC N/A
ROA(3y)47.16%
ROA(5y)45.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VRSN Yearly ROA, ROE, ROICVRSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

1.3 Margins

VRSN has a better Profit Margin (50.45%) than 100.00% of its industry peers.
In the last couple of years the Profit Margin of VRSN has remained more or less at the same level.
Looking at the Operating Margin, with a value of 67.95%, VRSN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
VRSN's Operating Margin has been stable in the last couple of years.
With an excellent Gross Margin value of 87.71%, VRSN belongs to the best of the industry, outperforming 97.53% of the companies in the same industry.
VRSN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 67.95%
PM (TTM) 50.45%
GM 87.71%
OM growth 3Y1.34%
OM growth 5Y0.75%
PM growth 3Y-5.15%
PM growth 5Y0.3%
GM growth 3Y0.84%
GM growth 5Y0.55%
VRSN Yearly Profit, Operating, Gross MarginsVRSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

2

2. Health

2.1 Basic Checks

VRSN does not have a ROIC to compare to the WACC, probably because it is not profitable.
VRSN has less shares outstanding than it did 1 year ago.
VRSN has less shares outstanding than it did 5 years ago.
The debt/assets ratio for VRSN is higher compared to a year ago.
VRSN Yearly Shares OutstandingVRSN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
VRSN Yearly Total Debt VS Total AssetsVRSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

VRSN has an Altman-Z score of -5.53. This is a bad value and indicates that VRSN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -5.53, VRSN is not doing good in the industry: 88.89% of the companies in the same industry are doing better.
VRSN has a debt to FCF ratio of 2.05. This is a good value and a sign of high solvency as VRSN would need 2.05 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 2.05, VRSN is doing good in the industry, outperforming 70.37% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.05
Altman-Z -5.53
ROIC/WACCN/A
WACC9.32%
VRSN Yearly LT Debt VS Equity VS FCFVRSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

2.3 Liquidity

A Current Ratio of 0.43 indicates that VRSN may have some problems paying its short term obligations.
The Current ratio of VRSN (0.43) is worse than 91.36% of its industry peers.
VRSN has a Quick Ratio of 0.43. This is a bad value and indicates that VRSN is not financially healthy enough and could expect problems in meeting its short term obligations.
VRSN's Quick ratio of 0.43 is on the low side compared to the rest of the industry. VRSN is outperformed by 90.12% of its industry peers.
Industry RankSector Rank
Current Ratio 0.43
Quick Ratio 0.43
VRSN Yearly Current Assets VS Current LiabilitesVRSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.50% over the past year.
Measured over the past years, VRSN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.54% on average per year.
VRSN shows a small growth in Revenue. In the last year, the Revenue has grown by 4.31%.
Measured over the past years, VRSN shows a small growth in Revenue. The Revenue has been growing by 4.80% on average per year.
EPS 1Y (TTM)10.5%
EPS 3Y13.17%
EPS 5Y8.54%
EPS Q2Q%4.17%
Revenue 1Y (TTM)4.31%
Revenue growth 3Y5.47%
Revenue growth 5Y4.8%
Sales Q2Q%3.94%

3.2 Future

VRSN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.59% yearly.
VRSN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.35% yearly.
EPS Next Y10.95%
EPS Next 2Y8.24%
EPS Next 3Y10.35%
EPS Next 5Y11.59%
Revenue Next Year4.28%
Revenue Next 2Y2.7%
Revenue Next 3Y4.69%
Revenue Next 5Y6.35%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
VRSN Yearly Revenue VS EstimatesVRSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
VRSN Yearly EPS VS EstimatesVRSN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15 20

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 30.83, the valuation of VRSN can be described as expensive.
VRSN's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of VRSN to the average of the S&P500 Index (28.29), we can say VRSN is valued inline with the index average.
VRSN is valuated quite expensively with a Price/Forward Earnings ratio of 27.79.
VRSN's Price/Forward Earnings ratio is in line with the industry average.
VRSN is valuated rather expensively when we compare the Price/Forward Earnings ratio to 21.08, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 30.83
Fwd PE 27.79
VRSN Price Earnings VS Forward Price EarningsVRSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

VRSN's Enterprise Value to EBITDA ratio is in line with the industry average.
VRSN's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 26.68
EV/EBITDA 22.04
VRSN Per share dataVRSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 -20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of VRSN may justify a higher PE ratio.
PEG (NY)2.82
PEG (5Y)3.61
EPS Next 2Y8.24%
EPS Next 3Y10.35%

0

5. Dividend

5.1 Amount

VRSN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

VERISIGN INC

NASDAQ:VRSN (4/17/2025, 8:00:02 PM)

After market: 246.67 0 (0%)

246.67

+0.74 (+0.3%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)02-06 2025-02-06/amc
Earnings (Next)04-24 2025-04-24/amc
Inst Owners82.02%
Inst Owner Change0.01%
Ins Owners0.7%
Ins Owner Change4.09%
Market Cap23.22B
Analysts80
Price Target248.58 (0.77%)
Short Float %2.27%
Short Ratio2.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.57%
Min EPS beat(2)-2.11%
Max EPS beat(2)0.97%
EPS beat(4)3
Avg EPS beat(4)0.51%
Min EPS beat(4)-2.11%
Max EPS beat(4)1.94%
EPS beat(8)5
Avg EPS beat(8)0.24%
EPS beat(12)7
Avg EPS beat(12)0.15%
EPS beat(16)10
Avg EPS beat(16)0.14%
Revenue beat(2)0
Avg Revenue beat(2)-1.85%
Min Revenue beat(2)-1.85%
Max Revenue beat(2)-1.85%
Revenue beat(4)0
Avg Revenue beat(4)-1.67%
Min Revenue beat(4)-1.85%
Max Revenue beat(4)-1.33%
Revenue beat(8)0
Avg Revenue beat(8)-1.84%
Revenue beat(12)0
Avg Revenue beat(12)-1.63%
Revenue beat(16)0
Avg Revenue beat(16)-1.66%
PT rev (1m)2.81%
PT rev (3m)11.43%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.67%
EPS NY rev (1m)0%
EPS NY rev (3m)0.6%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.25%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.79%
Valuation
Industry RankSector Rank
PE 30.83
Fwd PE 27.79
P/S 14.98
P/FCF 26.68
P/OCF 25.85
P/B N/A
P/tB N/A
EV/EBITDA 22.04
EPS(TTM)8
EY3.24%
EPS(NY)8.88
Fwd EY3.6%
FCF(TTM)9.24
FCFY3.75%
OCF(TTM)9.54
OCFY3.87%
SpS16.46
BVpS-20.7
TBVpS-21.25
PEG (NY)2.82
PEG (5Y)3.61
Profitability
Industry RankSector Rank
ROA 55.86%
ROE N/A
ROCE -849.28%
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 67.95%
PM (TTM) 50.45%
GM 87.71%
FCFM 56.15%
ROA(3y)47.16%
ROA(5y)45.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)-172.55%
ROCE(5y)-63.29%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y1.34%
OM growth 5Y0.75%
PM growth 3Y-5.15%
PM growth 5Y0.3%
GM growth 3Y0.84%
GM growth 5Y0.55%
F-Score7
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.05
Debt/EBITDA 1.36
Cap/Depr 76.15%
Cap/Sales 1.8%
Interest Coverage 250
Cash Conversion 82.42%
Profit Quality 111.3%
Current Ratio 0.43
Quick Ratio 0.43
Altman-Z -5.53
F-Score7
WACC9.32%
ROIC/WACCN/A
Cap/Depr(3y)79.48%
Cap/Depr(5y)88.52%
Cap/Sales(3y)2.26%
Cap/Sales(5y)2.84%
Profit Quality(3y)109.8%
Profit Quality(5y)101.96%
High Growth Momentum
Growth
EPS 1Y (TTM)10.5%
EPS 3Y13.17%
EPS 5Y8.54%
EPS Q2Q%4.17%
EPS Next Y10.95%
EPS Next 2Y8.24%
EPS Next 3Y10.35%
EPS Next 5Y11.59%
Revenue 1Y (TTM)4.31%
Revenue growth 3Y5.47%
Revenue growth 5Y4.8%
Sales Q2Q%3.94%
Revenue Next Year4.28%
Revenue Next 2Y2.7%
Revenue Next 3Y4.69%
Revenue Next 5Y6.35%
EBIT growth 1Y5.76%
EBIT growth 3Y6.88%
EBIT growth 5Y5.59%
EBIT Next Year12.78%
EBIT Next 3Y7%
EBIT Next 5Y8.16%
FCF growth 1Y8.23%
FCF growth 3Y5.06%
FCF growth 5Y4.15%
OCF growth 1Y5.72%
OCF growth 3Y3.79%
OCF growth 5Y3.67%